EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C32H38D6F6O4 |
| Net Charge | 0 |
| Average Mass | 612.725 |
| Monoisotopic Mass | 612.35204 |
| SMILES | [H][C@@]12CC[C@]([H])([C@H](CC#CC(O)(C(F)(F)F)C(F)(F)F)CCCC(O)(C([2H])([2H])[2H])C([2H])([2H])[2H])[C@@]1(C)CCC/C2=C\C=C1\C[C@@H](O)C[C@H](O)C1=C |
| InChI | InChI=1S/C32H44F6O4/c1-20-23(18-24(39)19-27(20)40)12-11-22-9-6-16-29(4)25(13-14-26(22)29)21(8-5-15-28(2,3)41)10-7-17-30(42,31(33,34)35)32(36,37)38/h11-12,21,24-27,39-42H,1,5-6,8-10,13-16,18-19H2,2-4H3/b22-11+,23-12-/t21-,24+,25+,26-,27-,29+/m0/s1/i2D3,3D3 |
| InChIKey | VSOWXEHVBCDXAY-DKRWUNOHSA-N |
| Roles Classification |
|---|
| Biological Roles: | vitamin D receptor agonist An agonist that binds to and activates vitamin D receptors fat-soluble vitamin (role) Any vitamin that dissolves in fats and are stored in body tissues. Unlike the water-soluble vitamins, they are stored in the body for long periods of time and generally pose a greater risk for toxicity when consumed in excess. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gemini-0072 (CHEBI:139243) has role antineoplastic agent (CHEBI:35610) |
| gemini-0072 (CHEBI:139243) has role vitamin D receptor agonist (CHEBI:139503) |
| gemini-0072 (CHEBI:139243) is a D3 vitamins (CHEBI:73558) |
| gemini-0072 (CHEBI:139243) is a deuterated compound (CHEBI:76107) |
| gemini-0072 (CHEBI:139243) is a hydroxycalciol (CHEBI:47042) |
| gemini-0072 (CHEBI:139243) is a organofluorine compound (CHEBI:37143) |
| gemini-0072 (CHEBI:139243) is a tetrol (CHEBI:33573) |
| IUPAC Name |
|---|
| (1R,3S,5Z)-4-methylidene-5-[(2E)-2-{(1R,3aS,7aR)-7a-methyl-1-[(6S)-1,1,1-trifluoro-2,10-dihydroxy-10-(2H3)methyl-2-(trifluoromethyl)(11,11,11-2H3)undec-3-yn-6-yl]octahydro-4H-inden-4-ylidene}ethylidene]cyclohexane-1,3-diol |
| Synonyms | Source |
|---|---|
| gemini-0072 | SUBMITTER |
| gemini0072 | SUBMITTER |
| (20S)-1α,25-dihydroxy-21-(3-hydroxy-3-trifluoromethyl-4,4,4-trifluoro-but-1-ynyl)-26,26,26,27,27,27-hexadeuterocholecalciferol | ChEBI |
| Citations |
|---|